Functionalized single-walled carbon nanotubes containing traces of iron as new negative MRI contrast agents for in vivo imaging

Contrast Media and Molecular Imaging

Volumn 7, Issue 2, 2012, Pages 153-159

  Doan, Bich Thuy ^a,b   Seguin, Johanne ^a   Breton, Marie ^a   Beherec, Ronan Le ^a   Bessodes, Michel ^a   Rodríguez Manzo, Julio A ^c   Banhart, Florian ^c   Beloeil, Jean Claude ^b   Scherman, Daniel ^a   Richard, Cyrille ^a  

^a PSL RESEARCH UNIVERSITY   (France)

^b CENTRE DE BIOPHYSIQUE MOLÉCULAIRE   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Carbon nanotubes; Functionalization; In vivo; MRI contrast agents; Traces of iron

Indexed keywords

CARBOXYLIC ACID; FERROMAGNETIC MATERIAL; GADOLINIUM PENTETATE; IRON OXIDE; LIPID; MACROGOL; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SINGLE WALLED NANOTUBE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; EX VIVO STUDY; FEMALE; HISTOLOGY; IN VIVO STUDY; MAGNETIC FIELD; MOUSE; NONHUMAN; PRIORITY JOURNAL; X RAY DIFFRACTION;

ANIMALS; CELL DEATH; CONTRAST MEDIA; HEP G2 CELLS; HUMANS; IMAGING, THREE-DIMENSIONAL; IRON; LIVER; LUNG; MAGNETIC RESONANCE IMAGING; MICE; NANOTUBES, CARBON; X-RAY DIFFRACTION;

EID: 84858725140     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.474     Document Type: Article

References (35)

1. Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 1999; 99: 2293-2352.
2. Sosnovik DE, Weissleder R. Emerging concepts in molecular MRI. Curr Opin Biotechnol 2007; 18: 4-10.
3. Shah K, Jacob A, Breakefield XO, Weissleder R. Molecular imaging of gene therapy for cancer. Gene Ther 2004; 11: 1175-1187.
4. Mulder WJM, Strijkers GJ, van Tilborg GAF, Griffioen AW, Nicolay K. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging. NMR Biomed 2006; 19: 142-164.
5. Terreno E, Castelli DD, Aime S. Encoding the frequency dependence in MRI contrast media: the emerging class of CEST agents. Contrast Media Mol Imag 2010; 5(2): 78-98.
6. Laurent S, Vander Elst L, Muller RN. Lanthanide complexes for magnetic resonance and optical molecular imaging. Q J Nucl Med Mol Imag 2009; 53(6): 586-603.
7. Iijima S. Helical microtubules of graphitic carbon. Nature 1991; 354: 56-58.
8. Bianco A, Kostarelos K, Partidos CD, Prato M. Biomedical applications of functionalised carbon nanotubes. Chem Commun 2005; 7: 571-577.
9. Lacerda L, Bianco A, Prato M, Kostarelos K. Carbon nanotubes as nanomedicines: from toxicology to pharmacology. Adv Drug Deliv Rev 2006; 58: 1460-1470.
10. Kam NW, Dai H. Carbon nanotubes as intracellular protein transporters: generality and biological functionality. J Am Chem Soc 2005; 127: 6021-6026.
11. Kostarelos K, Bianco A, Prato M. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. Nat Nanotechnol 2009; 4(10): 627-633.
12. Kam NW, O'Connell M, Wisdom JA, Dai H. Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci USA 2005; 102(33): 11600-11605.
13. 2 MRI contrast agents. Nano Lett 2008; 8(1): 232-236.
14. Al Faraj A, Cieslar K, Lacroix G, Gaillard S, Canet-Soulas E, Crémillieux Y. In vivo imaging of carbon nanotube biodistribution using magnetic resonance imaging. Nano Lett 2009; 9: 1023-1027.
15. Hamidi M, Azadi A, Rafiei P. Pharmacokinetic consequences of pegylation. Drug Deliv 2006; 13: 399-409.
16. Roseng L, Tolleshaug H, Berg T. Uptake, intracellular transport, and degradation of polyethylene glycol-modified asialofetuin in hepatocytes. J Biol Chem 1992; 267: 22987-2293.
17. Smith B, Wepasnick K, Schrote K E, Cho H-H, Ball WP, Fairbrother DH. Influence of surface oxides on the colloidal stability of multi-walled carbon nanotubes: a structure-property relationship. Langmuir 2009; 25(17): 767-776.
18. Silva JF, Griveau S, Richard C, Zagal JH, Bedioui F. Glassy carbon electrodes modified with single walled carbon nanotubes and cobalt phthalocyanine and nickel tetrasulfonated phthalocyanine: highly stable new hydrids with enhanced electrocatalytic performances. Electrochem Commun 2007; 9: 1629-1634.
19. 2-weighted MRI contrast agents. J Phys Chem 2009; 113: 19369-19372.
20. Gambarota G, van Laarhovenb HW, Philippens M, Lok J, van der Kogel A, Punt CJ, Heerschap A. Assessment of absolute blood volume in carcinoma by USPIO contrast-enhanced MRI. Magn Reson Imag 2006; 24: 279-286.
21. Sitharaman B, Kissell KR, Hartman KB, Tran LA, Baikalov A, Rusakova I, Sun Y, Khant HA, Ludtke SJ, Chiu W, Laus S, Tóth E, Helm L, Merbach AE, Wilson LJ. Superparamagnetic gadonanotubes are high-performance MRI contrast agents. Chem Commun 2005; 31: 3915-3917.
22. Sitharaman B, Wilson LJ. Gadonanotubes as new high-performance MRI contrast agents. Int J Nanomed 2006; 1(3): 291-295.
23. Hartman KB, Wilson LJ. Carbon nanostructures as a new high-performance platform for MR molecular imaging. Adv Exp Med Biol 2007; 620: 74-84.
24. Hartman KB, Laus S, Bolskar RD, Muthupillai R, Helm L, Toth E, Merbach AE, Wilson LJ. Gadonanotubes as ultrasensitive pH-smart probes for magnetic resonance imaging. Nano Lett 2008; 8(2): 415-419.
25. Saxena RK, William W, Mcgee JK, Daniels MJ, Boykin E, Gilmour MI. Enhanced in vitro and in vivo toxicity of poly-dispersed acid-functionalized single-wall carbon nanotubes. Nanotoxicology 2007; 1(4): 291-300.
26. Yang ST, Guo W, Lin Y, Deng XY, Wang HF, Sun HF, Liu YF, Wang X, Wang W, Chen M, Huang YP, Sun YP. Biodistribution of pristine single-walled carbon nanotubes in vivo. J Phys Chem C 2007; 111: 17761-17764.
27. Liu Z, Cai W, He L, Nakayama N, Chen K, Sun X, Chen X, Dai H. In vivo biodistribution and highly efficient tumor targeting of carbon nanotubes in mice. Nat Nanotechnol 2007; 2: 47-52.
28. Lam CW, James JT, McCluskey R, Arepalli S, Hunter RL. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit Rev Toxicol 2006; 36: 189-217.
29. Donaldson K, Aitken R, Tran L, Stone V, Duffin R, Forrest G, Alexander A. Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. Toxicol Sci 2006; 92: 5-22.
30. Helland A, Wick P, Koehler A, Schmid K, Som C. Reviewing the environmental and human health knowledge base of carbon nanotubes. Environ Health Perspect 2007; 115: 1125-1131.
31. Boczkowski J, Lanone S. Potential uses of carbon nanotubes in the medical field: how worried should patients be? Nanomedicine 2007; 2: 407-410.
32. Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 2005; 113: 823-839.
33. Lewinski N, Colvin V, Drezek R. Cytotoxicity of nanoparticles. Small 2008; 4: 26-49.
34. Poland C, Duffin R, Kinloch I, Maynard A, Wallace W, Seaton A, Stone V, Brown S, McNee W, Donaldson K. Carbon nanotubes introduced into the abdominal cavity ofmice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 2008; 3: 423-428.
35. Schipper ML, Nakayama-Ratchford N, Davis CR, Wong Shi Kam N, Chu P, Liu Z, Sun X, Dai H, Gambhir SS. A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. Nat Nanotechnol 2008; 3(4): 216-221.